Home
>
National Drug Code (NDC)
>
Imipenem and Cilastatin
Imipenem and Cilastatin - 63323-322-25 - (Imipenem and Cilastatin Sodium)
Drug Information of Imipenem and Cilastatin
| Product NDC: | 63323-322 |
| Proprietary Name: | Imipenem and Cilastatin |
| Non Proprietary Name: | Imipenem and Cilastatin Sodium |
| Active Ingredient(s): | 500; 500 mg/1; mg/1 & nbsp; Imipenem and Cilastatin Sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Imipenem and Cilastatin
| Product NDC: | 63323-322 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090577 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120103 |
Package Information of Imipenem and Cilastatin
| Package NDC: | 63323-322-25 |
| Package Description: | 25 VIAL, GLASS in 1 CARTON (63323-322-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
NDC Information of Imipenem and Cilastatin
| NDC Code | 63323-322-25 |
| Proprietary Name | Imipenem and Cilastatin |
| Package Description | 25 VIAL, GLASS in 1 CARTON (63323-322-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, GLASS |
| Product NDC | 63323-322 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Imipenem and Cilastatin Sodium |
| Dosage Form Name | INJECTION, POWDER, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120103 |
| Marketing Category Name | ANDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | CILASTATIN SODIUM; IMIPENEM |
| Strength Number | 500; 500 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Carbapenems [Chemical/Ingredient],Penem Antibacterial [EPC],Dipeptidase Inhibitors [MoA],Renal Dehydropeptidase Inhibitor [EPC] |
